• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Increased Plasma and Platelet Transfusion Ratios Associated with Decreased Mortality

November 7, 2012

A recently published prospective cohort study of ten level I trauma centers in the US suggests that increased ratios of plasma: red blood cells (RBC) and platelets:RBCs were independently associated with decreased mortality within 6 hours of admission. Led by Dr. John Holcomb of the University of Texas Health Science Center, the study enrolled 905 adult trauma patients who survived at least 30 minutes after admission and received at least 1 unit of RBCs within six hours of admission and at least three units of RBCs within 24 hours. Using a time-dependent model, researchers assessed the association of increased plasma and platelet ratios on in-hospital mortality. Within the first six hours, patients with ratios of less than 1:2 were found to be 3 to 4 times more likely to die than patients with ratios of 1:1. During the first six hours, the majority of mortality was attributed to hemorrhage. No association between plasma:RBC or platelet:RBC ratios and mortality was observed after 24 hours of admission, when the majority of mortality was attributed to non-hemorrhagic causes.

Reference

1.    Holcomb JB, Del Junco DJ, Fox EE, Wade CE, Cohen MJ, Schreiber MA, Alarcon LH, Bai Y, Brasel KJ, Bulger EM, Cotton BA, Matijevic N, Muskat P, Myers JG, Phelan HA, White CE, Zhang J, Rahbar MH; for the PROMMTT Study Group. The Prospective, Observational, Multicenter, Major Trauma Transfusion (PROMMTT) Study: Comparative Effectiveness of a Time-Varying Treatment With Competing Risks. Arch Surg. 2012 Oct 15:1-10. doi: 10.1001/2013.jamasurg.387.

Filed Under

  • Coagulation & Plasma Transfusion
  • News
  • Platelet Transfusion

Recommended

  • Neutralizing Antibodies to SARS-CoV-2 Persist for at Least 5 Months

  • New Alkaline Storage Solution Does Not Improve Post-Transfusion Recovery

  • ABO-incompatible Platelet Transfusions and Platelet Recovery in Patients with Intracerebral Hemorrhage

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • New Erythropoietin Gene Variants Linked to Hereditary Erythrocytosis

  • Multifaceted Threats to the Blood Supply from Climate Change

  • Distinct Roles for Differently Aged Platelets

  • Anemia Treatment Bundle Improves Hemoglobin Recovery after Critical Illness

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley